Posts tagged access

President Obama is expected to push for finalization of the Trans-Pacific Partnership (TPP) in tonight’s State of the Union address. MSF is deeply concerned that unless damaging provisions are removed before negotiations are finalized, the TPP agreement could become the most harmful trade pact ever for access to medicines in developing countries. Read why and help us fight back: http://bit.ly/ZLBmEl

President Obama is expected to push for finalization of the Trans-Pacific Partnership (TPP) in tonight’s State of the Union address. MSF is deeply concerned that unless damaging provisions are removed before negotiations are finalized, the TPP agreement could become the most harmful trade pact ever for access to medicines in developing countries. Read why and help us fight back: http://bit.ly/ZLBmEl

The Trans-Pacific Partnership (TPP): A Threat to Affordable Medicines for Millions

The TPP trade deal is currently being negotiated between the US and ten other Pacific Rim nations: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam. The agreement is slated to further expand its membership, potentially to all 21 Asia Pacific APEC nations. The negotiations, which began in 2010, are being conducted in secret, without the opportunity for public scrutiny. However, leaked drafts of the United States government’s proposals for some sections of the agreement reveal the inclusion of dangerous provisions that would dismantle public health safeguards enshrined in international law and restrict access to affordable generic medicines for millions of people in developing countries. To learn more visit, msfaccess.org/TPP

Countries Must Fix Critical Access to Medicines Flaws in Trans-Pacific Trade Pact
Negotiations on the Trans-Pacific Partnership (TPP)—a far-reaching trade agreement between 11 Pacific Rim countries—continue to be shrouded in secrecy, but leaked copies of the agreement reveal that the United States is demanding the most harmful package of intellectual property protections ever proposed for a trade agreement with developing countries.
These rules would make it extremely difficult for generic competitors to enter the market, keeping prices unaffordably high, with devastating public health consequences.
Follow us throughout the week as negotiations for the TPP restart in Lima, Peru, tomorrow. 
TAKE ACTION: Tell Members of Congress to Protect Access to Lifesaving Medicins

Countries Must Fix Critical Access to Medicines Flaws in Trans-Pacific Trade Pact

Negotiations on the Trans-Pacific Partnership (TPP)—a far-reaching trade agreement between 11 Pacific Rim countries—continue to be shrouded in secrecy, but leaked copies of the agreement reveal that the United States is demanding the most harmful package of intellectual property protections ever proposed for a trade agreement with developing countries.

These rules would make it extremely difficult for generic competitors to enter the market, keeping prices unaffordably high, with devastating public health consequences.

Follow us throughout the week as negotiations for the TPP restart in Lima, Peru, tomorrow. 

TAKE ACTION: Tell Members of Congress to Protect Access to Lifesaving Medicins

Dear GAVI Campaign | Vaccines: The right tools for this job? 

You know what it’s like when you don’t have the right tools for the job?

We do - because to protect children right now, we have to use vaccines that aren’t well suited to the job they have to do. We need better-adapted vaccines to reach the one in five children currently unprotected by full immunisation.

Find out more: msfaccess.org/vaccines

MSF Access: Dear GAVI Campaign

Children are now protected with 11 vaccines; up from six vaccines a decade ago. The price of vaccinating a child has sky-rocketed. It cost $1.37 to vaccinate a child 10 years ago, now it’s $38.80. That’s a whopping 2,700 percent increase. So how do we decide how many vaccines children need? Is it based on how much money 

Help MSF and send GAVI a message on Twitter asking for them to open up their lower prices to non-governmental organisations and humanitarian actors like MSF now.

CLICK HERE TO SEND A TWEET.

MSF Access: Dear GAVI Campaign
MSF vaccinates millions of people each year and fully supports the introduction of new vaccines in developing countries. But negotiations between companies and the largely taxpayer-funded GAVI Alliance for the newest vaccines have not resulted in deeper price cuts that would help more children benefit. The lack of transparency by companies on vaccine manufacturing costs and their focus on profits above ensuring sustainable prices for vaccines for low-income countries are at the root of the problem.
Help MSF and send GAVI a message on Twitter asking for them to open up their lower prices to non-governmental organisations and humanitarian actors like MSF now.
CLICK HERE TO SEND A TWEET.

MSF Access: Dear GAVI Campaign

MSF vaccinates millions of people each year and fully supports the introduction of new vaccines in developing countries. But negotiations between companies and the largely taxpayer-funded GAVI Alliance for the newest vaccines have not resulted in deeper price cuts that would help more children benefit. The lack of transparency by companies on vaccine manufacturing costs and their focus on profits above ensuring sustainable prices for vaccines for low-income countries are at the root of the problem.

Help MSF and send GAVI a message on Twitter asking for them to open up their lower prices to non-governmental organisations and humanitarian actors like MSF now.

CLICK HERE TO SEND A TWEET.

MSF Access: Dear GAVI Campaign
“Urgent action is needed to address the skyrocketing price to vaccinate a child, which has risen by 2,700 percent over the last decade,” said Dr. Manica Balasegaram, Executive Director of MSF’s Access Campaign. “Countries where we work will lose their donor support to pay for vaccines soon, and will have to decide which killer diseases they can and can’t afford to protect their children against.”
Help MSF, send GAVI a message on Twitter asking for them to open up their lower prices to non-governmental organisations and humanitarian actors like MSF now.
CLICK HERE TO SEND A TWEET.

MSF Access: Dear GAVI Campaign

“Urgent action is needed to address the skyrocketing price to vaccinate a child, which has risen by 2,700 percent over the last decade,” said Dr. Manica Balasegaram, Executive Director of MSF’s Access Campaign. “Countries where we work will lose their donor support to pay for vaccines soon, and will have to decide which killer diseases they can and can’t afford to protect their children against.”

Help MSF, send GAVI a message on Twitter asking for them to open up their lower prices to non-governmental organisations and humanitarian actors like MSF now.

CLICK HERE TO SEND A TWEET.

MSF Access: Dear GAVI Campaign
The GAVI Alliance negotiates price reductions for newer vaccines and, through its donors (such as the UK, the US and Norway), pays for these vaccines to be introduced in developing countries. MSF fully supports GAVI’s mission, but is concerned that the prices agreed for vaccines are still too high, and wants GAVI to put more pressure on the pharmaceutical companies to bring prices down further.
Help MSF, send GAVI a message on Twitter asking for them to open up their lower prices to non-governmental organisations and humanitarian actors like MSF now.
CLICK HERE TO SEND A TWEET.

MSF Access: Dear GAVI Campaign

The GAVI Alliance negotiates price reductions for newer vaccines and, through its donors (such as the UK, the US and Norway), pays for these vaccines to be introduced in developing countries. MSF fully supports GAVI’s mission, but is concerned that the prices agreed for vaccines are still too high, and wants GAVI to put more pressure on the pharmaceutical companies to bring prices down further.

Help MSF, send GAVI a message on Twitter asking for them to open up their lower prices to non-governmental organisations and humanitarian actors like MSF now.

CLICK HERE TO SEND A TWEET.

Indian Supreme Court Decision on Novartis Case a Victory for Access to Medicines in Developing Countries

“This is a huge relief for the millions of patients and doctors in developing countries who depend on affordable medicines from India, and for treatment providers like MSF,” said Dr. Unni Karunakara, MSF’s international president.

BREAKING NEWSNovartis has lost its case in Indian Supreme Court today, protecting access to affordable, quality medicines for people in developing countries. 

BREAKING NEWS
Novartis has lost its case in Indian Supreme Court today, protecting access to affordable, quality medicines for people in developing countries. 

Test Me, Treat Me: A Drug-Resistant TB Manifesto
The cost of DR-TB drugs are so high that most of the people affected by DR-TB do not have access to life saving medications. For the “lucky” ones that do have access, the treatment is long and painful. It can take up to 2 years, 14,6000 pills, and 8 months worth of daily injections to cure DR-TB. Many people living with DR-TB drop out of treatment plans because it severely hampers daily functioning and ability to maintain a normal lifestyle.
We need better treatment now! Learn more about the manifesto.

Test Me, Treat Me: A Drug-Resistant TB Manifesto

The cost of DR-TB drugs are so high that most of the people affected by DR-TB do not have access to life saving medications. For the “lucky” ones that do have access, the treatment is long and painful. It can take up to 2 years, 14,6000 pills, and 8 months worth of daily injections to cure DR-TB. Many people living with DR-TB drop out of treatment plans because it severely hampers daily functioning and ability to maintain a normal lifestyle.

We need better treatment now! Learn more about the manifesto.

Test Me, Treat Me: The MSF TB Manifesto from MSF on Vimeo.

The MSF TB Manifesto: Test Me, Treat Me

The last TB drug was created in the 60’s. That means that for the past 50 years, TB has developed drug resistance, and continues to spread without new medicines for treatment. It is time to demand more, and demand better treatment for drug-resistant TB. 

MSF’s patients and staff are calling for: universal access to diagnosis and treatment for drug-resistant TB, research to find shorter, less toxic and more effective treatments, and funding to increase care and research.

Test Me, Treat Me: A Drug-Resistant TB Manifesto
As the epidemic continues to spread, Drug-resistant TB becomes increasingly hard to tackle. The treatment is too long, too toxic, and too costly – the drugs alone cost at least $4,000 just to treat one person. We want to save many more lives, but we desperately need shorter, safer and more effective treatment to do so.
We, the undersigned people with DR-TB and those involved in their care, here raise the alarm about the devastating toll this disease is taking on us, our families and communities across the globe, and therefore make the following three demands:
1) We call for universal access to DR-TB diagnosis and treatment now.2) We call for better treatment regimens: the TB research community, including research institutes and drug companies, must urgently deliver effective, more tolerable, shorter and affordable DR-TB drug regimens.3) We call for more financial support to increase DR-TB treatment, and a commitment to support research into developing better treatment

Test Me, Treat Me: A Drug-Resistant TB Manifesto

As the epidemic continues to spread, Drug-resistant TB becomes increasingly hard to tackle. The treatment is too long, too toxic, and too costly – the drugs alone cost at least $4,000 just to treat one person. We want to save many more lives, but we desperately need shorter, safer and more effective treatment to do so.

We, the undersigned people with DR-TB and those involved in their care, here raise the alarm about the devastating toll this disease is taking on us, our families and communities across the globe, and therefore make the following three demands:

1) We call for universal access to DR-TB diagnosis and treatment now.
2) We call for better treatment regimens: the TB research community, including research institutes and drug companies, must urgently deliver effective, more tolerable, shorter and affordable DR-TB drug regimens.
3) We call for more financial support to increase DR-TB treatment, and a commitment to support research into developing better treatment

Test Me, Treat Me: A Drug-Resistant TB Manifesto
We, the people infected with drug-resistant TB (DR-TB), live in every part of the world. Most of us were exposed and became infected with DR-TB because of the poor conditions in which we live. Undiagnosed, this disease spreads among us. Untreated, this disease kills. But in the countries in which we live, fast and accurate diagnosis is rarely available, and only about one in five of us actually get effective DR-TB treatment. 
Those of us “lucky” enough to receive treatment have to go through an excruciating two-year journey where we must swallow up to 20 pills a day and receive a painful injection every day for the first 8 months, making it hard to sit or even lie down. For many of us, the treatment makes us feel sicker than the disease itself, as it causes nausea, body aches, and rashes. The drugs make many of us go deaf permanently, and some of us develop psychosis.

Test Me, Treat Me: A Drug-Resistant TB Manifesto

We, the people infected with drug-resistant TB (DR-TB), live in every part of the world. Most of us were exposed and became infected with DR-TB because of the poor conditions in which we live. Undiagnosed, this disease spreads among us. Untreated, this disease kills. But in the countries in which we live, fast and accurate diagnosis is rarely available, and only about one in five of us actually get effective DR-TB treatment.

Those of us “lucky” enough to receive treatment have to go through an excruciating two-year journey where we must swallow up to 20 pills a day and receive a painful injection every day for the first 8 months, making it hard to sit or even lie down. For many of us, the treatment makes us feel sicker than the disease itself, as it causes nausea, body aches, and rashes. The drugs make many of us go deaf permanently, and some of us develop psychosis.

Photo: Serovikov’s relatives are afraid to visit him in the hospital. Many patients like him suffer due to stigmatization around TB Kyrgyzstan 2013 © Vincent Tremeau
Surviving Two Years of Treatment for Drug-Resistant TB in Kyrgyzstan
It can take up to 2 years to treat drug-resistant TB. That means taking 20 pills a day (a total of 14,6000 pills) and getting 8 months of painful daily injections. We need better treatment now.
MSF works in the penitentiary and civilian sectors in Kyrgyzstan offering treatment for multi-drug resistant TB. 

Photo: Serovikov’s relatives are afraid to visit him in the hospital. Many patients like him suffer due to stigmatization around TB Kyrgyzstan 2013 © Vincent Tremeau

Surviving Two Years of Treatment for Drug-Resistant TB in Kyrgyzstan

It can take up to 2 years to treat drug-resistant TB. That means taking 20 pills a day (a total of 14,6000 pills) and getting 8 months of painful daily injections. We need better treatment now.

MSF works in the penitentiary and civilian sectors in Kyrgyzstan offering treatment for multi-drug resistant TB.